Kontigo Care AB (publ) (KONT.ST)
SEK 2.64
(-1.49%)
SEK 2.64
(-1.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 28.94 Million SEK | 1.8% |
| 2022 | 28.43 Million SEK | 15.86% |
| 2021 | 24.54 Million SEK | 20.44% |
| 2020 | 20.37 Million SEK | 15.68% |
| 2019 | 17.61 Million SEK | 33.16% |
| 2018 | 13.22 Million SEK | 112.3% |
| 2017 | 6.23 Million SEK | 475.79% |
| 2016 | 1.08 Million SEK | 41523.73% |
| 2015 | 2600.00 SEK | -99.95% |
| 2014 | 5.48 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 7.59 Million SEK | 2.3% |
| 2024 Q2 | 7.47 Million SEK | -1.55% |
| 2023 Q3 | 7.14 Million SEK | -2.1% |
| 2023 Q4 | 7.42 Million SEK | 3.9% |
| 2023 FY | 28.94 Million SEK | 1.8% |
| 2023 Q1 | 7.07 Million SEK | -1.06% |
| 2023 Q2 | 7.29 Million SEK | 3.12% |
| 2022 Q3 | 7.17 Million SEK | -1.98% |
| 2022 FY | 28.43 Million SEK | 15.86% |
| 2022 Q2 | 7.31 Million SEK | 7.62% |
| 2022 Q1 | 6.79 Million SEK | 2.75% |
| 2022 Q4 | 7.15 Million SEK | -0.22% |
| 2021 Q3 | 6.24 Million SEK | 4.84% |
| 2021 FY | 24.54 Million SEK | 20.44% |
| 2021 Q1 | 5.73 Million SEK | 1.21% |
| 2021 Q2 | 5.95 Million SEK | 3.77% |
| 2021 Q4 | 6.61 Million SEK | 6.02% |
| 2020 Q4 | 5.66 Million SEK | 8.4% |
| 2020 Q3 | 5.22 Million SEK | 6.22% |
| 2020 FY | 20.37 Million SEK | 15.68% |
| 2020 Q2 | 4.92 Million SEK | 7.91% |
| 2020 Q1 | 4.56 Million SEK | -1.85% |
| 2019 FY | 17.61 Million SEK | 33.16% |
| 2019 Q3 | 4.59 Million SEK | 4.98% |
| 2019 Q4 | 4.64 Million SEK | 1.06% |
| 2019 Q2 | 4.38 Million SEK | 9.75% |
| 2019 Q1 | 3.99 Million SEK | 12.64% |
| 2018 Q4 | 3.54 Million SEK | 6.44% |
| 2018 Q3 | 3.32 Million SEK | 3.61% |
| 2018 Q1 | 3.14 Million SEK | 32.64% |
| 2018 Q2 | 3.21 Million SEK | 2.19% |
| 2018 FY | 13.22 Million SEK | 112.3% |
| 2017 Q2 | 1.2 Million SEK | 36.21% |
| 2017 FY | 6.23 Million SEK | 475.79% |
| 2017 Q4 | 2.37 Million SEK | 33.09% |
| 2017 Q1 | 881 Thousand SEK | 98.77% |
| 2017 Q3 | 1.78 Million SEK | 48.42% |
| 2016 Q1 | 193 Thousand SEK | 7323.08% |
| 2016 Q4 | 443.21 Thousand SEK | 92.7% |
| 2016 Q2 | 215 Thousand SEK | 11.4% |
| 2016 FY | 1.08 Million SEK | 41523.73% |
| 2016 Q3 | 230 Thousand SEK | 6.98% |
| 2015 FY | 2600.00 SEK | -99.95% |
| 2015 Q4 | 2600.00 SEK | -99.85% |
| 2015 Q1 | 2.22 Million SEK | -26.07% |
| 2015 Q2 | 3.36 Million SEK | 51.21% |
| 2015 Q3 | 1.76 Million SEK | -47.58% |
| 2014 Q4 | 3.01 Million SEK | 169.32% |
| 2014 Q1 | 675.5 Thousand SEK | 0.0% |
| 2014 FY | 5.48 Million SEK | 0.0% |
| 2014 Q3 | 1.11 Million SEK | -17.17% |
| 2014 Q2 | 1.35 Million SEK | 100.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aino Health AB (publ) | 23.91 Million SEK | -21.025% |
| Bonzun AB (publ) | 2.73 Million SEK | -958.046% |
| Medhelp Care Aktiebolag (publ) | 84.08 Million SEK | 65.572% |
| RaySearch Laboratories AB (publ) | 1.02 Billion SEK | 97.168% |
| Surgical Science Sweden AB (publ) | 882.85 Million SEK | 96.721% |